The Washington Tax & Public Policy Group O/b/o Alliance for Biopharma
lobbying firm
Based in DC
🤖
AI Overview
With $155K in lobbying spend across 14 quarterly filings, The Washington Tax & Public Policy Group O/b/o Alliance for Biopharma is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2023.
$155K
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $35K |
| 2021 | $60K |
| 2022 | $40K |
| 2023 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation
- •Issues related to the taxation of the biopharmaceutical industry including international taxation
- •Issues related to corporate and international tax, including issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico and issues related to th
- •Issues related to corporate and international tax, including issues related to rates, tax code section 951A, issues related to the taxation of manufacturing income and capital investment in the United
- •Issues related to corporate and international tax, including issues related to corporate tax rates, issues related to the taxation of foreign income, tax code sections 951A and 954(c)(6), issues relat
- •Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250 and 59A
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.